ClinVar Miner

Submissions for variant NM_000051.4(ATM):c.5352C>T (p.Asn1784=)

gnomAD frequency: 0.00006  dbSNP: rs140641762
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000162510 SCV000212901 likely benign Hereditary cancer-predisposing syndrome 2015-05-08 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV000988695 SCV000558435 likely benign Ataxia-telangiectasia syndrome 2024-01-28 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000162510 SCV000682264 likely benign Hereditary cancer-predisposing syndrome 2016-08-05 criteria provided, single submitter clinical testing
GeneDx RCV000732576 SCV000714708 likely benign not provided 2021-03-09 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 21933854)
Eurofins Ntd Llc (ga) RCV000732576 SCV000860546 uncertain significance not provided 2018-04-10 criteria provided, single submitter clinical testing
Mendelics RCV000988695 SCV001138519 likely benign Ataxia-telangiectasia syndrome 2019-05-28 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000732576 SCV001475561 likely benign not provided 2019-12-10 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000162510 SCV002528431 likely benign Hereditary cancer-predisposing syndrome 2021-01-31 criteria provided, single submitter curation
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000732576 SCV002774251 likely benign not provided 2021-08-18 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV004589675 SCV005083946 benign Familial cancer of breast 2024-05-23 criteria provided, single submitter clinical testing This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004700498 SCV005203543 likely benign not specified 2024-07-16 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004551378 SCV004784846 likely benign ATM-related disorder 2020-01-15 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.